Skip to main content
. 2021 Aug 3;12(9):2437–2450. doi: 10.1007/s13300-021-01107-w

Fig. 3.

Fig. 3

Proportion of participants in the exenitide (n = 35), Humalog Mix25 (n = 37), and OAD (n = 28) groups that had the following shifts in timing of peak glucose before and after medication: shift to an earlier peak (black bars), no shift (light gray bars), or shift to a later peak (dark gray bars). E exenatide, H Humalog Mix25, O OADs